Pfizer and Nektar Therapeutics released a joint statement today announcing they have resolved all outstanding contractual issues related to Exubera and Nektar's Phase I next generation inhaled insulin (NGI) product.
The FDA said today it has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg) as an OTC product for adults and children 12 years of age and older.
Cephalon said it will pay $425 million to settle a US Justice Department investigation into practices of off-label marketing of products including its pain reliever Actiq.
Merck will pay $4.85 billion to settle the nearly 27,000 Vioxx lawsuits filed against the company by persons or family members claiming the drug injured or caused the death of its users.
AstraZeneca announced that the FDA has approved Crestor (rosuvastatin calcium) as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol.
MedAccess, a division of Access Communications, has been named agency of record for Stiefel Laboratories, brought on board to help with the launch of skin-care products, Extina and RevalèSkin.
Webcast
5 BIG REASONS for taking pharmaceutical marketing online
Available on demand Many pharmaceutical marketers are still unsure about entering the digital landscape and even less certain of what to do when they get there. Interactive marketing experts from Google and pharmaceutical companies discuss why marketers should take the plunge and how it could positively impact their businesses. Click here for more information and to register for this webcast.
To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.
All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam filter rules, please
use this domain name.
Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York
N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150 http://www.mmm-online.com/
You are subscribed as: %%EMAIL%%